The endpoint inflammation score-which was based on high-sensitivity C-reactive protein , interleukin-6 , tumor necrosis factor - , and plasminogen activator inhibitor-1 levels-was significantly lower ( P = 0.012 ) in the low-protein group ( 6.81 2.32 versus 7.94 1.94 ) .